{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:17:52Z","timestamp":1762161472509,"version":"3.40.5"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2020,3,17]]},"abstract":"<jats:sec><jats:title>Objective:<\/jats:title><jats:p>This mini-review aims to discuss research works about heparanase published in 2016, 2017, 2018 and 2019 and provide a direction for therapy methods targeting heparanase.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods:<\/jats:title><jats:p>The relevant data were searched by using keywords \u201cheparanase\u201d \u201cfunction\u201d, \u201cdiseases\u201d and \u201cinhibitors\u201d in \u201cPubMed\u201d, \u201cWeb of Science\u201d and \u201cChina Knowledge Resource Integrated databases (CNKI)\u201d, and a hand-search was done to acquire peer-reviewed articles and reports about heparanase.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Except for tumor progression, pathological processes including procoagulant activities, preeclamptic placentas, inflammation and so on are all verified to be associated with heparanase activity. Also, these newly-found functions are closely related to certain cellular activities, including epithelial to Mesenchymal Transition (EMT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>It could be concluded that heparanase would be a potential and valuable therapy target.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557519666190913150959","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T19:00:51Z","timestamp":1568401251000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Advances of Heparanase in Human Diseases"],"prefix":"10.2174","volume":"20","author":[{"given":"Hao","family":"Jin","sequence":"first","affiliation":[{"name":"The Second Department of General Surgery, Zhuhai People\u2019s Hospital, No. 79 of Kangning Road, Xiangzhou District, Zhuhai City, Guangdong Province, 519000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-8507","authenticated-orcid":true,"given":"Min","family":"Cui","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, Zhuhai People\u2019s Hospital, No. 79 of Kangning Road, Xiangzhou District, Zhuhai City, Guangdong Province, 519000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/1389557516666161101143643","volume":"17","author":"Jin H.","year":"2017","unstructured":"Jin H.; Zhou S.; The functions of heparanase in human diseases. Mini Rev Med Chem 2017,17(6),541-548","journal-title":"Mini Rev Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"Brabletz T.","year":"2018","unstructured":"Brabletz T.; Kalluri R.; Nieto M.A.; Weinberg R.A.; EMT in cancer. Nat Rev Cancer 2018,18(2),128-134","journal-title":"Nat Rev Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/ndt\/gfw403","volume":"32","author":"Masola V.","year":"2017","unstructured":"Masola V.; Granata S.; Bellin G.; Gambaro G.; Onisto M.; Rugiu C.; Lupo A.; Zaza G.; Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. Nephrol Dial Transplant 2017,32(7),1145-1154","journal-title":"Nephrol Dial Transplant"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S0959-8049(17)30338-6","volume":"72","author":"Shah S.","year":"2017","unstructured":"Shah S.; Fourgeaud C.; Derieux, Mirshahi S, Soria J, Contant G, Pimi C, Lo Dico R, Eveno C, Ullah M, Kaci R, Pocard M, Mirshahi M. 611A \u2013 The close relationship between heparanase and epithelial mesenchymal transition related fibrosis in gastric signet-ring cell adenocarcinoma. Eur J Cancer 2017,72,S79-S79","journal-title":"Eur J Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0049-3848(07)70139-1","volume":"120","author":"Vlodavsky I.","year":"2007","unstructured":"Vlodavsky I.; Ilan N.; Nadir Y.; Brenner B.; Katz B.Z.; Naggi A.; Torri G.; Casu B.; Sasisekharan R.; Heparanase, heparin and the coagulation system in cancer progression. Thromb Res 2007,120(Suppl. 2),S112-S120","journal-title":"Thromb Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/jth.13707","volume":"15","author":"Crispel Y.","year":"2017","unstructured":"Crispel Y.; Ghanem S.; Attias J.; Kogan I.; Brenner B.; Nadir Y.; Involvement of the heparanase procoagulant domain in bleeding and wound healing. J Thromb Haemost 2017,15(7),1463-1472","journal-title":"J Thromb Haemost"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/eurheartj\/ehx493.P5425","volume":"38","author":"Bayam E.","year":"2017","unstructured":"Bayam E.; Kalcik M.; Yesin M.; Gunduz S.; Gursoy M.O.; Karakoyun S.; Cersit S.; Gurbuz A.S.; Efe S.C.; Yaman A.; Guner A.; Kalkan S.; Ozkan M.; P5425 Relationship between heparanase levels and prosthetic valve thrombosis: Clinical implications. Eur Heart J 2017,38,1151-1152","journal-title":"Eur Heart J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/ejh.12997","volume":"100","author":"Matan M.","year":"2018","unstructured":"Matan M.; King D.; Peled E.; Ackerman S.; Bar-Lavi Y.; Brenner B.; Nadir Y.; Heparanase level and procoagulant activity are reduced in severe sepsis. Eur J Haematol 2018,100(2),182-188","journal-title":"Eur J Haematol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/cbin.10748","volume":"41","author":"Barbosa G.O.","year":"2017","unstructured":"Barbosa G.O.; Cervigne N.K.; Carvalho H.F.; Augusto T.M.; Heparanase 1 involvement in prostate physiopathology. Cell Biol Int 2017,41(11),1194-1202","journal-title":"Cell Biol Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"19403","DOI":"10.18632\/oncotarget.14292","volume":"8","author":"Goldberg R.","year":"2017","unstructured":"Goldberg R.; Sonnenblick A.; Hermano E.; Hamburger T.; Meirovitz A.; Peretz T.; Elkin M.; Heparanase augments insulin receptor signaling in breast carcinoma. Oncotarget 2017,8(12),19403-19412","journal-title":"Oncotarget"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.18632\/oncotarget.23560","volume":"9","author":"Vornicova O.","year":"2017","unstructured":"Vornicova O.; Naroditsky I.; Boyango I.; Shachar S.S.; Mashiach T.; Ilan N.; Vlodavsky I.; Bar-Sela G.; Prognostic significance of heparanase expression in primary and metastatic breast carcinoma. Oncotarget 2017,9(5),6238-6244","journal-title":"Oncotarget"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"43521","DOI":"10.18632\/oncotarget.16575","volume":"8","author":"Sun X.","year":"2017","unstructured":"Sun X.; Zhang G.; Nian J.; Yu M.; Chen S.; Zhang Y.; Yang G.; Yang L.; Cheng P.; Yan C.; Ma Y.; Meng H.; Wang X.; Li J.P.; Elevated heparanase expression is associated with poor prognosis in breast cancer: A study based on systematic review and TCGA data. Oncotarget 2017,8(26),43521-43535","journal-title":"Oncotarget"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1535-7163.MCT-16-0900","volume":"16","author":"Spyrou A.","year":"2017","unstructured":"Spyrou A.; Kundu S.; Haseeb L.; Yu D.; Olofsson T.; Dredge K.; Hammond E.; Barash U.; Vlodavsky I.; Forsberg-Nilsson K.; Inhibition of heparanase in pediatric brain tumor cells attenuates their proliferation, invasive capacity, and in vivo tumor growth. Mol Cancer Ther 2017,16(8),1705-1716","journal-title":"Mol Cancer Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/jnci\/djy032","volume":"110","author":"Barash U.","year":"2018","unstructured":"Barash U.; Lapidot M.; Zohar Y.; Loomis C.; Moreira A.; Feld S.; Goparaju C.; Yang H.; Hammond E.; Zhang G.; Li J.P.; Ilan N.; Nagler A.; Pass H.I.; Vlodavsky I.; Involvement of heparanase in the pathogenesis of mesothelioma: Basic aspects and clinical applications. J Natl Cancer Inst 2018,110(10),1102-1114","journal-title":"J Natl Cancer Inst"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/dna.2017.3990","volume":"37","author":"Yang S.","year":"2018","unstructured":"Yang S.; Liao Y.; Zhao Q.; Xie Y.; Zheng A.; Wan H.; Heparanase is a critical regulator of mitotic spindles required for maintaining chromosome stability. DNA Cell Biol 2018,37(4),291-297","journal-title":"DNA Cell Biol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/aps.2017.189","volume":"39","author":"Wei R.R.","year":"2018","unstructured":"Wei R.R.; Sun D.N.; Yang H.; Yan J.; Zhang X.; Zheng X.L.; Fu X.H.; Geng M.Y.; Huang X.; Ding J.; CTC clusters induced by heparanase enhance breast cancer metastasis. Acta Pharmacol Sin 2018,39(8),1326-1337","journal-title":"Acta Pharmacol Sin"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/JCI92958","volume":"127","author":"Putz E.M.","year":"2017","unstructured":"Putz E.M.; Mayfosh A.J.; Kos K.; Barkauskas D.S.; Nakamura K.; Town L.; Goodall K.J.; Yee D.Y.; Poon I.K.; Baschuk N.; Souza-Fonseca-Guimaraes F.; Hulett M.D.; Smyth M.J.; NK cell heparanase controls tumor invasion and immune surveillance. J Clin Invest 2017,127(7),2777-2788","journal-title":"J Clin Invest"},{"key":"ref=18","first-page":"129","volume":"47","author":"Martin L.","year":"2017","unstructured":"Martin L.; Chen J.M.; Zechendorf E.; Chiazza F.; Oggero S.; Collino M.; Marx G.; Schuerholz T.; Thiemermann C.; Role of the beta-D-endoglucuronidase heparanase in septic cardiomyopathy. Shock 2017,47,129-129","journal-title":"Shock"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3892\/ijo.2018.4503","volume":"53","author":"Lv Q.","year":"2018","unstructured":"Lv Q.; Wu K.; Liu F.; Wu W.; Chen Y.; Zhang W.; Interleukin-17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer. Int J Oncol 2018,53(4),1809-1817","journal-title":"Int J Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3502386","volume":"2017","author":"Garc\u00eda B.","year":"2017","unstructured":"Garc\u00eda B.; Garc\u00eda-Su\u00e1rez O.; Merayo-Lloves J.; Ferrara G.; Alcalde I.; Gonz\u00e1lez J.; Lisa C.; Alfonso J.F.; Vazquez F.; Quir\u00f3s L.M.; Heparanase overexpresses in keratoconic cornea and tears depending on the pathologic grade. Dis Markers 2017,2017","journal-title":"Dis Markers"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-017-0912-8","volume":"14","author":"Changyaleket B.","year":"2017","unstructured":"Changyaleket B.; Chong Z.Z.; Dull R.O.; Nanegrungsunk D.; Xu H.; Heparanase promotes neuroinflammatory response during subarachnoid hemorrhage in rats. J Neuroinflammation 2017,14(1),137","journal-title":"J Neuroinflammation"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.placenta.2017.06.006","volume":"57","author":"Hambruch N.","year":"2017","unstructured":"Hambruch N.; Kumstel S.; Haeger J.D.; Pfarrer C.; Bovine placentomal heparanase and syndecan expression is related to placental maturation. Placenta 2017,57,42-51","journal-title":"Placenta"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.12891\/ceog3796.2018","volume":"45","author":"Mu Y.Q.","year":"2018","unstructured":"Mu Y.Q.; Wang J.; Liu R.H.; Qi C.X.; Xi G.P.; Zhao F.X.; Zhu Z.Y.; Expression of heparanase in the spontaneously aborted human chorionic villus. Clin Exp Obstet Gynecol 2018,45,174-177","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00005-016-0396-8","volume":"65","author":"Szymczak M.","year":"2017","unstructured":"Szymczak M.; Ku\u017aniar J.; Kope\u0107 W.; \u017babi\u0144ska M.; Marchewka Z.; Ko\u015bcielska-Kasprzak K.; Klinger M.; Increased granulocyte heparanase activity in neutrophils from patients with lupus nephritis and idiopathic membranous nephropathy. Arch Immunol Ther Exp (Warsz) 2017,65(1),83-91","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"34191","DOI":"10.18632\/oncotarget.16573","volume":"8","author":"Abassi Z.","year":"2017","unstructured":"Abassi Z.; Hamoud S.; Hassan A.; Khamaysi I.; Nativ O.; Heyman S.N.; Muhammad R.S.; Ilan N.; Singh P.; Hammond E.; Zaza G.; Lupo A.; Onisto M.; Bellin G.; Masola V.; Vlodavsky I.; Gambaro G.; Involvement of heparanase in the pathogenesis of acute kidney injury: Nephroprotective effect of PG545. Oncotarget 2017,8(21),34191-34204","journal-title":"Oncotarget"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"i365","DOI":"10.1093\/ndt\/gfy104.SP059","volume":"33","author":"Valentina M.","year":"2018","unstructured":"Valentina M.; Simona G.; Giovanni G.; Antonio L.; Gianluigi Z.; SP059 heparanase a key regulator of the chronic profibrotic kidney damage following ischemia\/reperfusion injury. Nephrol Dial Transplant 2018,33,i365-i365","journal-title":"Nephrol Dial Transplant"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens6030043","volume":"6","author":"Thakkar N.","year":"2017","unstructured":"Thakkar N.; Yadavalli T.; Jaishankar D.; Shukla D.; Emerging roles of heparanase in viral pathogenesis. Pathogens 2017,6(3),1-12","journal-title":"Pathogens"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.celrep.2017.06.041","volume":"20","author":"Agelidis A.M.","year":"2017","unstructured":"Agelidis A.M.; Hadigal S.R.; Jaishankar D.; Shukla D.; Viral activation of heparanase drives pathogenesis of herpes simplex virus-1. Cell Rep 2017,20(2),439-450","journal-title":"Cell Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"14956","DOI":"10.1038\/s41598-017-14946-0","volume":"7","author":"Secchi M.F.","year":"2017","unstructured":"Secchi M.F.; Crescenzi M.; Masola V.; Russo F.P.; Floreani A.; Onisto M.; Heparanase and macrophage interplay in the onset of liver fibrosis. Sci Rep 2017,7(1),14956","journal-title":"Sci Rep"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2019.01.001","volume":"529","author":"Khanna M.","year":"2019","unstructured":"Khanna M.; Ranasinghe C.; Browne A.M.; Li J.P.; Vlodavsky I.; Parish C.R.; Is host heparanase required for the rapid spread of heparan sulfate binding viruses? Virology 2019,529(1),1-6","journal-title":"Virology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.matbio.2016.11.007","volume":"62","author":"Xiong A.","year":"2017","unstructured":"Xiong A.; Kundu S.; Forsberg M.; Xiong Y.; Bergstr\u00f6m T.; Paavilainen T.; Kjell\u00e9n L.; Li J.P.; Forsberg-Nilsson K.; Heparanase confers a growth advantage to differentiating murine embryonic stem cells, and enhances oligodendrocyte formation. Matrix Biol 2017,62,92-104","journal-title":"Matrix Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-161298","volume":"58","author":"Garc\u00eda B.","year":"2017","unstructured":"Garc\u00eda B.; Mart\u00edn C.; Garc\u00eda-Su\u00e1rez O.; Mu\u00f1iz-Alonso B.; Ordiales H.; Fern\u00e1ndez-Men\u00e9ndez S.; Santos-Juanes J.; Lorente-Gea L.; Casta\u00f1\u00f3n S.; Vicente-Etxenausia I.; Pi\u00f1a Batista K.M.; Ruiz-D\u00edaz I.; Caballero-Mart\u00ednez M.C.; Merayo-Lloves J.; Guerra-Merino I.; Quir\u00f3s L.M.; Fern\u00e1ndez-Vega I.; Upregulated expression of heparanase and heparanase 2 in the brains of Alzheimer\u2019s disease. J Alzheimers Dis 2017,58(1),185-192","journal-title":"J Alzheimers Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneuroim.2017.07.001","volume":"310","author":"Changyaleket B.","year":"2017","unstructured":"Changyaleket B.; Deliu Z.; Chignalia A.Z.; Feinstein D.L.; Heparanase: Potential roles in multiple sclerosis. J Neuroimmunol 2017,310,72-81","journal-title":"J Neuroimmunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1038\/s41598-018-23070-6","volume":"8","author":"Whitehead M.J.","year":"2018","unstructured":"Whitehead M.J.; McGonigal R.; Willison H.J.; Barnett S.C.; Heparanase attenuates axon degeneration following sciatic nerve transection. Sci Rep 2018,8(1),5219","journal-title":"Sci Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/dvdy.12","volume":"248","author":"Barbosa G.O.","year":"2019","unstructured":"Barbosa G.O.; Bruni-Cardoso A.; da Silva Pinhal M.A.; Augusto T.M.; Carvalho H.F.; Heparanase-1 activity and the early postnatal prostate development. Dev Dyn 2019,248(3),211-220","journal-title":"Dev Dyn"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2018.12.027","volume":"283","author":"Aldi S.","year":"2019","unstructured":"Aldi S.; Eriksson L.; Kronqvist M.; Lengquist M.; L\u00f6fling M.; Folkersen L.; Matic L.P.; Maegdefessel L.; Grinnemo K.H.; Li J.P.; \u00d6sterholm C.; Hedin U.; Dual roles of heparanase in human carotid plaque calcification. Atherosclerosis 2019,283,127-136","journal-title":"Atherosclerosis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.carbpol.2018.10.071","volume":"205","author":"Sistla J.C.","year":"2019","unstructured":"Sistla J.C.; Morla S.; Alabbas A.B.; Kalathur R.C.; Sharon C.; Patel B.B.; Desai U.R.; Polymeric fluorescent heparin as one-step FRET substrate of human heparanase. Carbohydr Polym 2019,205(1),385-391","journal-title":"Carbohydr Polym"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1016\/j.bmcl.2017.08.013","volume":"27","author":"Rondanin R.","year":"2017","unstructured":"Rondanin R.; Fochi S.; Baruchello R.; Bernardi T.; Oliva P.; Semeraro F.; Simoni D.; Giannini G.; Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors. Bioorg Med Chem Lett 2017,27(18),4421-4425","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.15252\/embr.201643581","volume":"18","author":"Li Y.","year":"2017","unstructured":"Li Y.; Zheng F.; Xiao X.; Xie F.; Tao D.; Huang C.; Liu D.; Wang M.; Wang L.; Zeng F.; Jiang G.; CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep 2017,18(9),1646-1659","journal-title":"EMBO Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-17-0242","volume":"23","author":"Dai X.","year":"2017","unstructured":"Dai X.; Yan J.; Fu X.; Pan Q.; Sun D.; Xu Y.; Wang J.; Nie L.; Tong L.; Shen A.; Zheng M.; Huang M.; Tan M.; Liu H.; Huang X.; Ding J.; Geng M.; Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase. Clin Cancer Res 2017,23(20),6267-6278","journal-title":"Clin Cancer Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9163","DOI":"10.1039\/C7CC04156J","volume":"53","author":"Loka R.S.","year":"2017","unstructured":"Loka R.S.; Yu F.; Sletten E.T.; Nguyen H.M.; Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity. Chem Commun (Camb) 2017,53(65),9163-9166","journal-title":"Chem Commun (Camb)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/md15050134","volume":"15","author":"Poupard N.","year":"2017","unstructured":"Poupard N.; Badarou P.; Fasani F.; Groult H.; Bridiau N.; Sannier F.; Bordenave-Juchereau S.; Kieda C.; Piot J.M.; Grillon C.; Fruitier-Arnaudin I.; Maugard T.; Assessment of heparanase-mediated angiogenesis using microvascular endothelial cells: Identification of \u03bb-carrageenan derivative as a potent anti angiogenic agent. Mar Drugs 2017,15(5),284-298","journal-title":"Mar Drugs"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.vetmic.2017.01.033","volume":"201","author":"Guo C.","year":"2017","unstructured":"Guo C.; Zhu Z.; Wang X.; Chen Y.; Liu X.; Pyrithione inhibits porcine reproductive and respiratory syndrome virus replication through interfering with NF-\u03baB and heparanase. Vet Microbiol 2017,201,231-239","journal-title":"Vet Microbiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3214-8","volume":"17","author":"Baburajeev C.P.","year":"2017","unstructured":"Baburajeev C.P.; Mohan C.D.; Rangappa S.; Mason D.J.; Fuchs J.E.; Bender A.; Barash U.; Vlodavsky I.; Basappa, Rangappa KS. Identification of novel class of triazolo-thiadiazoles as potent inhibitors of human heparanase and their anticancer activity. BMC Cancer 2017,17,1-14","journal-title":"BMC Cancer"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3892\/or.2016.5269","volume":"37","author":"Lou C.","year":"2017","unstructured":"Lou C.; Zhu Z.; Zhao Y.; Zhu R.; Zhao H.; Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2\/-9 and heparanase in MDA-MB-231 cells. Oncol Rep 2017,37(1),179-184","journal-title":"Oncol Rep"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/hon.2466","volume":"36","author":"Rossini A.","year":"2018","unstructured":"Rossini A.; Zunino F.; Ruggiero G.; De Cesare M.; Cominetti D.; Tortoreto M.; Lanzi C.; Cassinelli G.; Zappasodi R.; Tripodo C.; Gulino A.; Zaffaroni N.; Di Nicola M.; Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat. Hematol Oncol 2018,36(1),360-362","journal-title":"Hematol Oncol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adfm.201707289","volume":"28","author":"Lang T.Q.","year":"2018","unstructured":"Lang T.Q.; Ran W.; Dong X.Y.; Zheng Z.; Liu Y.; Yin Q.; Li Y.P.; Tumor cells-selective bionic nanodevice exploiting heparanase combats metastatic breast cancer. Adv Funct Mater 2018,28,1-9","journal-title":"Adv Funct Mater"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1021\/acsami.8b17625","volume":"11","author":"Loka R.S.","year":"2019","unstructured":"Loka R.S.; Sletten E.T.; Barash U.; Vlodavsky I.; Nguyen H.M.; Specific inhibition of heparanase by a glycopolymer with well-defined sulfation pattern prevents breast cancer metastasis in mice. ACS Appl Mater Interfaces 2019,11(1),244-254","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/exd.13876","volume":"28","author":"Iriyama S.","year":"2019","unstructured":"Iriyama S.; Yamanishi H.; Kunizawa N.; Hirao T.; Amano S.; 1-(2-Hydroxyethyl)-2-imidazolidinone, a heparanase and matrix metalloproteinase inhibitor, improves epidermal basement membrane structure and epidermal barrier function. Exp Dermatol 2019,28(3),247-253","journal-title":"Exp Dermatol"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T18:29:50Z","timestamp":1664389790000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174858\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557519666190913150959","relation":{},"ISSN":["1389-5575"],"issn-type":[{"type":"print","value":"1389-5575"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}